TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01764035

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Body Scan (BS) Meditation Intervention
Description: This intervention consists of 4 individual 60-minute sessions (week 1, 2, 4, and 6) in which participants learn the body scan meditation exercise and practice it at home, daily, lying in bed at their usual bedtime after going to bed (and when waking up at night, unable to go back to sleep). The Body-Scan meditation consists of a 30-minute exercise during which participants are guided to focus their attention on certain parts of their body (e.g. toes, feet). The core skill involves gradually adopting an observant, non-judgmental, and accepting stance towards bodily sensations, including feelings and thoughts.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Brief Supportive Psychotherapy (SP)
Description: SP is a common form of non-specific psychotherapy available to patients with bipolar disorder in the community. It focuses on addressing a patient's current concerns, supporting a patient's adaptive coping skills, improving self-esteem, and expressing feelings and the therapeutic alliance. Using a conversational style, SP involves conveying empathy, validation, comforting and supporting patients in coping with distress about current life issues as well as providing encouragement and praise, clarification and opportunity to vent. SP will match BS in length, number of sessions and delivery schedule (four, 60-minute sessions, week 1, 2, 4, 6).
Study: NCT02680899

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Curricular Intervention
Description: The intervention is a novel grades 7 and 8 InSciEd Out curriculum in mental health and addiction called My Mind, My Body.
Study: NCT03989479

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brushing demonstration using T shaped toothbrush
Description: Brushing demonstration given at baseline and reinforced at 2 weeks and 1 month

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Brushing demonstration using conventional toothbrush
Description: Brushing demonstration given at baseline and reinforced at 2 weeks and 1 month
Study: NCT03460704

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CMS
Description: 1 MIU equivalent to 80 mg colistimethate sodium diluted in 1 mL saline solution 0.45%. Investigational Medicinal Product (IMP) glass vials were shrink wrapped in opaque white plastic and provided in boxes of 30 vials (two weeks of b.i.d. dosing).~The 1 MIU/ml CMS/0.45% saline solution was transferred from the glass vial into a specific nebuliser system fitted with a 0.3 mL medication chamber, for administration by inhalation. This delivered a nominal dose of 0.3 MIU/24 mg CMS (11 mg CBA) from the device.~The first dose of the IMP was administered at the site under the supervision of the site staff and subjects were instructed how to prepare and self-administer the IMP at home via a specific nebuliser system, b.i.d. (morning and evening) over aperiod of 12 month.~At least 10 minutes (min) before each administration, an inhaled short-acting bronchodilator (e.g. salbutamol/albuterol), supplied by the Sponsor, could be taken to improve tolerability.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 1 mL saline solution 0.45%. The placebo was made up of identical empty glass vials to which the same saline solution diluent was added in exactly the same way as the reconstitution of the active treatment by injecting the diluent through the rubber stopper. The glass vials were shrink wrapped with opaque white plastic to mantain the blind.
Study: NCT01299961

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: abatacept
Description: 125 mg once a week up to 12 months.
Study: NCT04719312

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Y modification of transconjunctival approach
Description: Section of the orbital septum is done at the Arcus Marginalis and subperiosteal dissection done to expose the infraorbital rim and orbital floor.~Subsequently, canthotomy of the superficial limb of the lateral canthal ligament is performed and subperiosteal dissection is carried out to expose the fracture at the frontozygomatic region.~The cutaneous Y will transform into a box when retracting its corners, increasing the working area and allowing access of the frontozygomatic (FZ) suture, lateral orbital wall, body of the zygoma, infraorbital rim, and floor of the orbit with a single approach.~A small upper vestibular incision is placed to expose the fracture at the zygomatic buttress. Reduction and fixation of fractures in a regular fashion are accomplished.
Study: NCT01162785

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SCH 721015
Description: Intravesical SCH 721015 (on Day 1 and 4) at a dose concentration of 3x1011particles/mL given in a 75 mL total volume. Administered into bladder through a urinary catheter, 75 mL will be instilled, left in the bladder for 1 hour, plus or minus 10 minutes. During the dwell time, subject will be repositioned from left to right, back and abdomen to maximize bladder surface exposure, approximately every 15 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SCH 721015
Description: Intravesical SCH 721015 (on Day 1 and 4) at a dose concentration of 3x1011particles/mL given in a 75 mL total volume. Administered into bladder through a urinary catheter, 75 mL will be instilled, left in the bladder for 1 hour, plus or minus 10 minutes. During the dwell time, subject will be repositioned from left to right, back and abdomen to maximize bladder surface exposure, approximately every 15 minutes.
Study: NCT03538808

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Varenicline
Description: Participants will be provided varenicline medication

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Varenicline
Description: Participants will be provided varenicline medication

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will be provided placebo medication

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will be provided placebo medication
Study: NCT03997500

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: a bolus of normal saline was given followed by normal saline infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Norepinephrine
Description: a bolus of norepinephrine was given followed by norepinephrine infusion
Study: NCT01564030

Intervention type: OTHER
Group type: OTHER
Intervention: Empty
Description: overnight fast

Intervention type: OTHER
Group type: OTHER
Intervention: Fluid
Description: 250mL apple juice

Intervention type: OTHER
Group type: OTHER
Intervention: Solid
Description: breakfast
Study: NCT01906320

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High-Intensity Resistance training
Description: Intervention group performed 3 weekly sessions during 8 weeks in the intra-hospital gymnasium. Each session lasted 50-60 min, and started and ended with warm-up and cool-down periods (10-15 min).~The core session included bench press, leg press, lateral row, leg extension, lateral pull-down, abdominal crunch, low back extension, and push-ups exercises. The participants performed three sets of 8-10 repetitions with resting periods of 1-2 min on the weightlifting machines. Load was gradually increased 5-10 % as the participant strength was adapted. The load started at 70% of 6RM.~Functional exercises (abdominal crunch, low back extension, and push-ups) were performed at the end of the session to strengthen the core musculature consisting of 3 sets of 15s of isometric contractions at the beginning of the program and 30 s at the end. Dynamic contractions were added, starting with 10 repetitions at the beginning to 30 repetitions at the end of the program.
Study: NCT05589090

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Super Skills for Life program
Description: Children in the experimental group received eight sessions of the Super Skills for Life protocol. The intervention was implemented using a structured manual for the therapist and a workbook for the children \[Orgilés, M., Espada, J.P., Ollendick, T.H. \& Essau, C. (2022). Programa Super Skills. Manual del aplicador. Elche, ES: Universidad Miguel Hernández\]. The intervention was administered via an online virtual platform for eight weeks, with each session lasting approximately one hour.
Study: NCT03043599

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Thoracic Radiation Therapy
Description: All participants will receive radiation therapy (3Gy x 10 fractions) to the chest for 10 days (Monday through Friday for 2 weeks).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: Ipilimumab 3 mg/kg (90 minute IV infusion) will be administered every 3 weeks for 4 doses.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Nivolumab 1 mg/kg (30 minute IV infusion) will be administered every 3 weeks for 4 doses, followed by nivolumab 480 mg every 4 weeks.
Study: NCT04437849

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Home Telemonitoring System
Description: Home Telemonitoring System (HTS) The HTS consists of an App that daily collects measurements of weight, blood pressure, heart rate and symptoms (checklist of symptoms questions). The HTS processes the data and generates and sends an alert to the physicians if a risk situation occurs (measurements are outside of normal ranges). The App has also an educational functionality that allows learning about lifestyle, self-care and healthy habits for HF patients. For this purpose, the application: a) has a section that answers frequent questions, b) has a question and answer game about HF, and c) sends educational messages to the patients every day.
Study: NCT02016339

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard care
Description: 24-h consultation telephone line to the sleep nurses to answer questions regarding CPAP usage. Patients were reviewed at 1 month and at 3 month intervals during the first year and every 6 months thereafter in the CPAP clinic by the nurse. Additional visits or phone calls by sleep specialist if doubts about a patient's compliance or willingness to continue with the therapy.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Intensive care
Description: Standard group care plus: Involvement of the patient's partner or family necessary. Extra education on sleep apnea and CPAP by sleep specialists via a 15-min videotape. 10- to 15-min lecture from the sleep clinic's nurses after CPAP titration study. Phone calls by nurses at 2 and 7 days. Early review of patients by sleep specialists at 15 and 30 days. Home visits by sleep nurses, if there doubts about a patients adherence
Study: NCT01530347

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Easy Check
Description: Collection of paired measurements of capillary blood glucose using reference method and data generated by the non invasive study device. Samples will be obtained at specific time points during 4 hours: at fasting, and after consuming standard liquid meal at 60, 120, 180 and 240 minutes.
Study: NCT01898494

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transoral surgery
Description: Undergo transoral surgical resection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transoral surgery
Description: Undergo transoral surgical resection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transoral surgery
Description: Undergo transoral surgical resection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transoral surgery
Description: Undergo transoral surgical resection

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: intensity-modulated radiation therapy
Description: Undergo standard-dose or low-dose IMRT

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: intensity-modulated radiation therapy
Description: Undergo standard-dose or low-dose IMRT
Study: NCT01898494

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: intensity-modulated radiation therapy
Description: Undergo standard-dose or low-dose IMRT

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cisplatin
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carboplatin
Description: Given IV
Study: NCT03442387

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Frame of numerical information
Description: Each group received only one frame of information.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Frame of numerical information
Description: Each group received only one frame of information.
Study: NCT05106062

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: on remote monitoring
Description: This group will turn on the RM function 0 to 45 days after defibrillator implantation. Patient should be seen at clinic once a year, or if there is any adverse event notification
Study: NCT02866331

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF (Leucostim)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF (Leucostim)

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CB (autologous cord blood)

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: CB (autologous cord blood)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (Normal saline)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (Normal saline)
Study: NCT03376529

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPR741
Description: 400 mg IV over 1 hour

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPR741
Description: 400 mg IV over 1 hour

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPR741
Description: 400 mg IV over 1 hour

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ceftazidime
Description: 1.0 gram IV over 1 hour

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam
Description: 4.5 grams IV over 1 hour

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aztreonam
Description: 1.0 gram IV over 1 hour
Study: NCT00772525

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nerispirdine
Description: form: tablet~Route: oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nerispirdine
Description: form: tablet~Route: oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nerispirdine
Description: form: tablet~Route: oral
Study: NCT00775944

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Proactive telephone support
Description: Pro-active telephone counselling allows for repeated, sequenced calls to be made by quitline counsellors to smokers and for counselling to be provided during accepted calls.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Proactive telephone support
Description: Pro-active telephone counselling allows for repeated, sequenced calls to be made by quitline counsellors to smokers and for counselling to be provided during accepted calls.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Reactive (standard) telephone support
Description: Reactive counselling usually involves the provision of evidence-based information to support quit attempts without any or with only very brief counselling to accompany it.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Reactive (standard) telephone support
Description: Reactive counselling usually involves the provision of evidence-based information to support quit attempts without any or with only very brief counselling to accompany it.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Offer of voucher for cost-free Nicotine Replacement Therapy
Description: Offer of voucher for cost-free Nicotine Replacement Therapy over the telephone

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Offer of voucher for cost-free Nicotine Replacement Therapy
Description: Offer of voucher for cost-free Nicotine Replacement Therapy over the telephone
Study: NCT00569829

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cognitive behavioral therapy
Description: 1 to 16 weekly sessions of modular cognitive behavioral therapy, each lasting 60-80 minutes
Study: NCT01455467

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: One iStent
Description: Implantation of one iStent in conjunction with cataract surgery

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Two iStent
Description: Implantation of two iStent in conjunction with cataract surgery
Study: NCT03402659

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: neflamapimod
Description: 40 mg neflamapimod capsule

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: matching placebo capsule
Study: NCT02906969

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Colonoscopy Educational Video
Description: Brief Video utilization to assess comprehension and evaluation bowel preparation quality

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Educational Video
Description: Brief Video utilization to provide placebo information and evaluation bowel preparation quality
Study: NCT03512015

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Lung Cancer App - LuCApp
Description: The Intervention Arm receiving LuCApp (The Lung Cancer App) in addition to standard care

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard care
Description: The Standard-of-Care patients receiving following the same schedule identified for LuCApp patients with paper questionnaires during clinic visits, or at home (having received paper questionnaires during the previous visit) or via telephonic interviews with the research team.
Study: NCT03071198

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: TME
Description: 1. Find the hypogastric nerve trunk in front of sacral promontory and protect it,be careful to use electrocautery hemostasis biased toward the side of rectal when handle lateral ligament of rectum and middle rectal artery and avoid to damage the pelvic plexus.~2. At least a 2-cm margin to the lower edge of the tumor is adequate for distal bowel resection. Resect 5cm length distal rectal or all of the mesorectum.Check the integrity of the mesorectum in postoperative routine examination. Double stapling method is used for all low anastomosis operations.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TME
Description: 1. Find the hypogastric nerve trunk in front of sacral promontory and protect it,be careful to use electrocautery hemostasis biased toward the side of rectal when handle lateral ligament of rectum and middle rectal artery and avoid to damage the pelvic plexus.~2. At least a 2-cm margin to the lower edge of the tumor is adequate for distal bowel resection. Resect 5cm length distal rectal or all of the mesorectum.Check the integrity of the mesorectum in postoperative routine examination. Double stapling method is used for all low anastomosis operations.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TME
Description: 1. Find the hypogastric nerve trunk in front of sacral promontory and protect it,be careful to use electrocautery hemostasis biased toward the side of rectal when handle lateral ligament of rectum and middle rectal artery and avoid to damage the pelvic plexus.~2. At least a 2-cm margin to the lower edge of the tumor is adequate for distal bowel resection. Resect 5cm length distal rectal or all of the mesorectum.Check the integrity of the mesorectum in postoperative routine examination. Double stapling method is used for all low anastomosis operations.

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Concurrent chemo-radiotherapy
Description: Three-dimensional conformal radiotherapy as following: CTV 44Gy/22 times＋GTV1 6Gy/3 times(2Gy/time/day，5 days a week，totally 5 weeks),if rectal tumors do not regress obviously, additional GTV2 is necessary, 5.4Gy/3 times (1.8Gy/time/day). At the same time, Capecitabine (850mg/m2, two times every day) will be taken on radiotherapy day
Study: NCT01630499

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Commercial Weight Loss Program (CWLP)
Description: This intervention is a generic, widely-available weight management program.
Study: NCT03071198

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Concurrent chemo-radiotherapy
Description: Three-dimensional conformal radiotherapy as following: CTV 44Gy/22 times＋GTV1 6Gy/3 times(2Gy/time/day，5 days a week，totally 5 weeks),if rectal tumors do not regress obviously, additional GTV2 is necessary, 5.4Gy/3 times (1.8Gy/time/day). At the same time, Capecitabine (850mg/m2, two times every day) will be taken on radiotherapy day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: neoadjuvant CT
Description: CAPEOX protocol:Oxaliplatin 130mg/m2 ivgtt 2-6h dl;(Capecitabine 1000mg/m2 2 times a day lasts for 14 days Repeat every 3 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: neoadjuvant CT
Description: CAPEOX protocol:Oxaliplatin 130mg/m2 ivgtt 2-6h dl;(Capecitabine 1000mg/m2 2 times a day lasts for 14 days Repeat every 3 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: adjuvant CT
Description: CAPEOX protocol:Oxaliplatin 130mg/m2 ivgtt 2-6h dl;(Capecitabine 1000mg/m2 2 times a day lasts for 14 days Repeat every 3 weeks
Study: NCT03477682

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Early ambulation
Description: Patients who are in the experimental arm will have a shorter duration of bedrest restriction following sartorius surgery (1 day) versus the standard group (5 days bedrest).
Study: NCT03727360

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Training
Description: Supervised exercise conducted four days per week for six months.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Flexibility Control
Description: Supervised exercise conducted four days per week for six months.
Study: NCT03071198

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adjuvant CT
Description: CAPEOX protocol:Oxaliplatin 130mg/m2 ivgtt 2-6h dl;(Capecitabine 1000mg/m2 2 times a day lasts for 14 days Repeat every 3 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adjuvant CT
Description: CAPEOX protocol:Oxaliplatin 130mg/m2 ivgtt 2-6h dl;(Capecitabine 1000mg/m2 2 times a day lasts for 14 days Repeat every 3 weeks
Study: NCT01101542

Intervention type: BIOLOGICAL
Intervention: Cervarix.
Description: Subjects will receive three doses of the Cervarix vaccine administered intramuscularly according to a 0, 1, 6 month vaccination schedule in routine clinical practice settings.

Intervention type: OTHER
Intervention: Data collection
Description: All adverse events will be recorded by all subjects or the subject's parents/guardians using diary cards.
Study: NCT02705027

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Freka®-Trilumina versus Freka®-EasyIn
Description: Direct placement of probe via endoscope

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Freka®-Trilumina versus Freka®-EasyIn
Description: Direct placement of probe via endoscope